JP2001506607A - セファロスポリン誘導体 - Google Patents

セファロスポリン誘導体

Info

Publication number
JP2001506607A
JP2001506607A JP52485698A JP52485698A JP2001506607A JP 2001506607 A JP2001506607 A JP 2001506607A JP 52485698 A JP52485698 A JP 52485698A JP 52485698 A JP52485698 A JP 52485698A JP 2001506607 A JP2001506607 A JP 2001506607A
Authority
JP
Japan
Prior art keywords
group
alkyl
hydrogen
pharmaceutically acceptable
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP52485698A
Other languages
English (en)
Japanese (ja)
Inventor
エム スプリンジャー，デーン
ワイ ルー，ビン
ブイ ダンドレア，スタンレー
ダブリュー ヒュディマ，トーマス
ケイ キム，オーク
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of JP2001506607A publication Critical patent/JP2001506607A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP52485698A 1996-11-27 1997-11-21 セファロスポリン誘導体 Pending JP2001506607A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3404696P 1996-11-27 1996-11-27
US60/034,046 1996-11-27
PCT/US1997/021785 WO1998023621A1 (en) 1996-11-27 1997-11-21 Cephalosporin derivatives

Publications (1)

Publication Number Publication Date
JP2001506607A true JP2001506607A (ja) 2001-05-22

Family

ID=21873971

Family Applications (1)

Application Number Title Priority Date Filing Date
JP52485698A Pending JP2001506607A (ja) 1996-11-27 1997-11-21 セファロスポリン誘導体

Country Status (17)

Country Link
EP (1) EP0966472A1 (hu)
JP (1) JP2001506607A (hu)
KR (1) KR20000057283A (hu)
CN (1) CN1238775A (hu)
AR (1) AR010650A1 (hu)
AU (1) AU734948B2 (hu)
BR (1) BR9713350A (hu)
CA (1) CA2272717A1 (hu)
CZ (1) CZ185399A3 (hu)
HU (1) HUP9903621A3 (hu)
IL (1) IL129437A0 (hu)
NO (1) NO992526D0 (hu)
NZ (1) NZ335892A (hu)
PL (1) PL334558A1 (hu)
TW (1) TW414796B (hu)
WO (1) WO1998023621A1 (hu)
ZA (1) ZA9710662B (hu)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014517837A (ja) * 2011-05-18 2014-07-24 シンジェンタ パーティシペーションズ アクチェンゲゼルシャフト アリールチオアセトアミド誘導体をベースとする殺虫化合物

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6265394B1 (en) * 1997-07-31 2001-07-24 Bristol-Myers Squibb Company Bis quaternary MRSA cephem derivatives
KR20020085178A (ko) * 2001-05-07 2002-11-16 주식회사 엘지생명과학 신규 세팔로스포린계 항생제 및 이의 제조 방법
KR20020085176A (ko) * 2001-05-07 2002-11-16 주식회사 엘지생명과학 신규 세팔로스포린계 항생제 및 이의 제조 방법
KR20020085180A (ko) * 2001-05-07 2002-11-16 주식회사 엘지생명과학 신규 세팔로스포린계 항생제 및 이의 제조 방법
KR20020085181A (ko) * 2001-05-07 2002-11-16 주식회사 엘지생명과학 신규 세팔로스포린계 항생제 및 이의 제조 방법
KR20030071311A (ko) * 2002-02-28 2003-09-03 주식회사 엘지생명과학 신규 세팔로스포린 화합물 및 그의 제조방법
CN105131018B (zh) * 2015-09-23 2017-12-26 浙江华方药业股份有限公司 一种头孢替唑酸的制备方法
CN114957056A (zh) * 2021-02-20 2022-08-30 帕潘纳(北京)科技有限公司 制备3-甲基-2-氯-4-甲基磺酰基苯甲酸甲酯及其中间体的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3345366A (en) * 1967-02-15 1967-10-03 American Cyanamid Co Substituted 7-acetylamino cephalosporanic acids
US4148997A (en) * 1977-11-07 1979-04-10 Yeda Research And Development Co., Ltd. 7-[Sulfomethyl)phenyl]acetamidocephalosporin derivatives
US5567698A (en) * 1995-02-15 1996-10-22 Bristol-Myers Squibb Company Pyridinium thiomethyl substituted chepholosporin derivatives
US5620969A (en) * 1995-04-25 1997-04-15 Bristol-Myers Squibb Company Cephalosporin derviatives
AU1278197A (en) * 1995-12-20 1997-07-14 Bristol-Myers Squibb Company Cephalosporin derivatives

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014517837A (ja) * 2011-05-18 2014-07-24 シンジェンタ パーティシペーションズ アクチェンゲゼルシャフト アリールチオアセトアミド誘導体をベースとする殺虫化合物

Also Published As

Publication number Publication date
BR9713350A (pt) 2000-01-25
KR20000057283A (ko) 2000-09-15
AU5365298A (en) 1998-06-22
NO992526L (no) 1999-05-26
NZ335892A (en) 2001-07-27
CA2272717A1 (en) 1998-06-04
WO1998023621A1 (en) 1998-06-04
TW414796B (en) 2000-12-11
CZ185399A3 (cs) 1999-08-11
AU734948B2 (en) 2001-06-28
EP0966472A4 (hu) 1999-12-29
CN1238775A (zh) 1999-12-15
NO992526D0 (no) 1999-05-26
PL334558A1 (en) 2000-03-13
IL129437A0 (en) 2000-02-17
AR010650A1 (es) 2000-06-28
ZA9710662B (en) 1999-05-26
EP0966472A1 (en) 1999-12-29
HUP9903621A2 (hu) 2000-04-28
HUP9903621A3 (en) 2001-05-28

Similar Documents

Publication Publication Date Title
EP0416410B1 (en) Piperaziniocephalosporins
JPH05509089A (ja) セファロスポリンおよび同族体、製法および医薬組成物
US6265394B1 (en) Bis quaternary MRSA cephem derivatives
JP2979235B2 (ja) 新規化合物、その製法及びそれを含む医薬組成物
WO1999032497A1 (fr) Derives de phosphonocephem, leur procede de preparation et leur utilisation
KR19990064201A (ko) 세팔로스포린 항생제
JP2001506607A (ja) セファロスポリン誘導体
US5668284A (en) Cephalosporin derivatives
US5559108A (en) Cephalosporin derivatives
US5620969A (en) Cephalosporin derviatives
US6093712A (en) Cephalosporin derivatives
US5734047A (en) Cephalosporin derivatives
JP3238209B2 (ja) チオメチルチオカルバセファロスポリン誘導体
D'Andrea et al. Synthesis and anti-MRSA activity of novel cephalosporin derivatives
JP2874987B2 (ja) 新規化合物、その製法及びそれを含む医薬組成物
IE863407L (en) 1-carba (dethia) cephalosporins
WO1997037997A1 (en) Cephalosporin derivatives
US20020049191A1 (en) Cephalosporin derivatives
AP199A (en) Novel B-Lactam and a novel class cephalosporins.
RU2172317C2 (ru) Производные цефалоспорина, содержащая их антибактериальная композиция, производные 2-аминотиазолов в качестве промежуточных соединений и способ их получения
JPH0414679B2 (hu)
WO1999006048A1 (en) Bis quaternary mrsa cephem derivatives
MXPA99004823A (en) Cephalosporin derivatives
CZ163291A3 (cs) Nové beta«laktamové sloučeniny
JPH05502665A (ja) 新規化合物